192 related articles for article (PubMed ID: 14689766)
21. You're the flight surgeon. Crohn's disease.
Hartwich SA
Aviat Space Environ Med; 2004 Aug; 75(8):716-7. PubMed ID: 15328792
[No Abstract] [Full Text] [Related]
22. [Mesalazine is effective in Crohn disease].
Quartarolo JP
Ugeskr Laeger; 2005 Apr; 167(16):1767. PubMed ID: 15898611
[No Abstract] [Full Text] [Related]
23. Case report: combination therapy with granulocyte apheresis and infliximab for refractory Crohn's disease.
González Carro P; Pérez Roldán F; Roncero García Escribano O; Lafuente R; Legaz Huidobro ML; Amigo Echenagusía A
J Clin Apher; 2006 Dec; 21(4):249-51. PubMed ID: 16607627
[No Abstract] [Full Text] [Related]
24. [Mesalazine is effective in Crohn disease 2].
Quartarolo JP; Laegemidler F; Eskerod O
Ugeskr Laeger; 2005 Mar; 167(11):1308-9; author reply 1309. PubMed ID: 15830510
[No Abstract] [Full Text] [Related]
25. [Mesalazine is effective in Crohn disease 1].
Fallingborg J; Langholz E; Christensen LA; Munkholm P; Dahlerup JF
Ugeskr Laeger; 2005 Mar; 167(11):1307-8; author reply 1309. PubMed ID: 15830509
[No Abstract] [Full Text] [Related]
26. Mesalazine-induced lupus.
Timsit MA; Anglicheau D; Lioté F; Marteau P; Dryll A
Rev Rhum Engl Ed; 1997 Oct; 64(10):586-8. PubMed ID: 9385697
[TBL] [Abstract][Full Text] [Related]
27. Metastatic Crohn's disease.
Marotta PJ; Reynolds RP
Am J Gastroenterol; 1996 Feb; 91(2):373-5. PubMed ID: 8607510
[TBL] [Abstract][Full Text] [Related]
28. [Mesalazine is without clinical effect in patients with Crohn disease].
Munck LK
Ugeskr Laeger; 2005 Jan; 167(3):302-3. PubMed ID: 15704804
[No Abstract] [Full Text] [Related]
29. Crohn's disease and secondary amyloidosis: early complication? A case report and review of the literature.
Basturk T; Ozagari A; Ozturk T; Kusaslan R; Unsal A
J Ren Care; 2009 Sep; 35(3):147-50. PubMed ID: 19689697
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of metastatic Crohn's disease with cyclosporine.
Carranza DC; Young L
J Drugs Dermatol; 2008 Aug; 7(8):789-91. PubMed ID: 18720698
[TBL] [Abstract][Full Text] [Related]
31. [Inflammatory diseases of the intestines].
Felley C; Guyot J; Hess J; Mottet C; Delarive J; Michetti P
Rev Med Suisse; 2006 Jan; 2(49):191-4, 196-8, 201-3. PubMed ID: 16493962
[TBL] [Abstract][Full Text] [Related]
32. [For treatment decision the age to be taken into account. In Crohn's disease and ulcerative colitis attention to be paid to the age at manifestation].
MMW Fortschr Med; 2009 May; 151(19):38-9. PubMed ID: 19827443
[No Abstract] [Full Text] [Related]
33. [Association between membranous glomerulonephritis and Crohn's disease].
Díaz Rodríguez C; Granja E; Vázquez Martul E; Sacristán F; Moreno Fernández A; González Rivero C; del Río Romero D; Trinidad JC
Nefrologia; 2004; 24(4):368-71. PubMed ID: 15455498
[TBL] [Abstract][Full Text] [Related]
34. Metastatic Crohn's disease mimicking genital pyoderma gangrenosum in an HIV patient.
Avilés-Izquierdo JA; Suárez-Fernández R; Lázaro-Ochaita P; Longo-Imedio I
Acta Derm Venereol; 2005; 85(1):60-2. PubMed ID: 15848994
[TBL] [Abstract][Full Text] [Related]
35. Prevention of postoperative recurrence in Crohn's disease.
Terdiman JP
Clin Gastroenterol Hepatol; 2008 Jun; 6(6):616-20. PubMed ID: 17967564
[No Abstract] [Full Text] [Related]
36. Mesalamine in the treatment of active Crohn's disease.
Dignass A; Marteau P
Gastroenterology; 2005 Jan; 128(1):245-6; author reply 246. PubMed ID: 15633152
[No Abstract] [Full Text] [Related]
37. Mesalamine maintenance therapy for Crohn's disease.
Feagan BG; McDonald JW
Gastroenterology; 2001 Feb; 120(2):585-6. PubMed ID: 11271451
[No Abstract] [Full Text] [Related]
38. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease].
Moum B
Tidsskr Nor Laegeforen; 2003 Sep; 123(18):2565-7. PubMed ID: 14714043
[TBL] [Abstract][Full Text] [Related]
39. Development of Crohn's disease in a patient taking etanercept.
Oh J; Arkfeld DG; Horwitz DA
J Rheumatol; 2005 Apr; 32(4):752-3. PubMed ID: 15801037
[TBL] [Abstract][Full Text] [Related]
40. Mesalamine and relapse prevention in Crohn's disease.
Cottone M; Cammà C
Gastroenterology; 2000 Aug; 119(2):597. PubMed ID: 10960274
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]